Clinical Trials Logo

Filter by:
  • Available  
  • Page [1]
NCT ID: NCT05935462 Available - Clinical trials for Digital Learning Aids for Special Children

A Preliminary Study on Digital Learning Aids for Special Children With TRIZ and 3D Printing Technology

Start date: n/a
Phase:
Study type: Expanded Access

During the transition phase from early intervention to primary education (4.5 years to 8.11 years), children with special needs may encounter difficulties in using digital learning media. The investigators intend to apply the TRIZ analysis method to enhance children's participation in learning. Additionally, the investigators plan to design a preliminary model of learning aids and conduct a trial.

NCT ID: NCT04327973 Available - Clinical trials for Pompe Disease Infantile-Onset

Expanded Access for ATB200/AT2221 for the Treatment of IOPD

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access program (EAP) for eligible participants designed to provide access to ATB200/AT2221.

NCT ID: NCT03994627 Available - Soft Tissue Sarcoma Clinical Trials

Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of soft tissue sarcoma (STS).

NCT ID: NCT03763604 Available - Clinical trials for Metastatic Breast Cancer

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Start date: n/a
Phase:
Study type: Expanded Access

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.